• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Raysearch Laboratories

222.20 SEK

+4.12 %

Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.12 %
+25.75 %
+16.95 %
-2.54 %
-4.02 %
-31.31 %
+222.50 %
+136.13 %
+298.38 %

RaySearch Laboratories operates in the medical technology industry and focuses on the development and manufacture of software for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The operations are international and target customers globally. RaySearch Laboratories was founded in 2000 and is headquartered in Stockholm, Sweden.

Read more
Market cap
7.62B SEK
Turnover
29.23M SEK
Revenue
1.34B
EBIT %
21.74 %
P/E
33.41
Dividend yield-%
1.8 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13/8
2026

Interim report Q2'26

3/11
2026

Interim report Q3'26

10/2
2027

Annual report '26

Press release6/5/2026, 7:35 AM

RaySearch Laboratories visar nya framsteg inom partikelbehandling på PTCOG 64

Raysearch Laboratories
Press release6/5/2026, 7:35 AM

RaySearch to showcase new advances in particle therapy at PTCOG 64

Raysearch Laboratories
Press release5/21/2026, 11:38 AM

Antony Lomax rekryteras till RaySearch för att stärka ledarskapet inom partikelbehandling

Raysearch Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/21/2026, 11:38 AM

Antony Lomax joins RaySearch to strengthen leadership in particle therapy

Raysearch Laboratories
Press release5/18/2026, 7:06 AM

Första patienterna behandlade med hjälp av RayCare vid Raigmore Hospital

Raysearch Laboratories
Press release5/18/2026, 7:06 AM

First patients treated with RayCare at Raigmore Hospital

Raysearch Laboratories
Press release5/13/2026, 3:30 PM

RaySearch visar banbrytande innovationer på ESTRO 2026

Raysearch Laboratories
Press release5/13/2026, 3:30 PM

RaySearch to showcase groundbreaking innovations at ESTRO 2026

Raysearch Laboratories
Press release5/12/2026, 8:05 AM

Första online adaptive-behandlingen med hjälp av RayStation och RayCare på TrueBeam

Raysearch Laboratories
Press release5/12/2026, 8:05 AM

First online adaptive treatment on TrueBeam using RayStation and RayCare

Raysearch Laboratories
Regulatory press release5/7/2026, 6:10 PM

Kommuniké från årsstämman 2026

Raysearch Laboratories
Regulatory press release5/7/2026, 6:10 PM

Bulletin from the Annual General Meeting 2026

Raysearch Laboratories
Regulatory press release4/29/2026, 5:30 AM

Delårsrapport första kvartalet 2026: Stark långsiktig utveckling och höjt marginalmål

Raysearch Laboratories
Regulatory press release4/29/2026, 5:30 AM

Interim report first quarter 2026: Strong long-term performance and raised margin target

Raysearch Laboratories
Press release4/27/2026, 8:20 AM

Institut Hartmann väljer RayStation och RayCare

Raysearch Laboratories
Press release4/27/2026, 8:20 AM

Institut Hartmann selects RayStation and RayCare

Raysearch Laboratories
Press release4/22/2026, 9:10 AM

Inbjudan till presentation av RaySearchs rapport för det första kvartalet 2026

Raysearch Laboratories
Press release4/22/2026, 9:10 AM

Invitation to presentation of RaySearch’s interim report for the first quarter of 2026

Raysearch Laboratories
Regulatory press release4/19/2026, 5:45 PM

Günther Mårder lämnar RaySearchs styrelse

Raysearch Laboratories
Regulatory press release4/19/2026, 5:45 PM

Günther Mårder resigns from the Board of RaySearch

Raysearch Laboratories